ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Pancreas transplantation"

  • 2021 American Transplant Congress

    Symptoms on MTSOSD Questionnaire in Pancreas Transplantation Recipients

    R. Kaur, S. R. Rizvi, B. H. Smith, C. Reid, S. K. McCrady-Spitzer, W. K. Kremers, P. G. Dean, A. Kukla, M. D. Stegall, Y. C. Kudva

    Mayo Clinic, Rochester, MN

    *Purpose: We used the Modified transplant symptom Occurrence and symptom distress scale (MTSOSD) to study side-effects of immunosuppression after Pancreas transplantation (PT) for patients with…
  • 2021 American Transplant Congress

    Dual-Agent Induction Therapy for Pancreas Transplantation: A Single-center Experience

    E. C. Liu1, J. H. Lee1, R. Craig-Schapiro2, M. Aull2, S. Sultan2

    1Pharmacy, NewYork-Presbyterian Weill Cornell Medical Center, New York, NY, 2Kidney/Pancreas Transplant Surgery, NewYork-Presbyterian Weill Cornell Medical Center, New York, NY

    *Purpose: The optimal induction strategy in pancreas transplantation has not been elucidated. Available evidence supports use of both basiliximab and lymphocyte depleting agents. Rabbit anti-thymocyte…
  • 2021 American Transplant Congress

    Impact of Insulin Therapy in Pancreas Transplantation Donors on Graft Outcomes: An Analysis of the Optn/unos Database

    E. Montagud-Marrahi1, F. Ausania2, Y. Fundora2, A. Amor3, E. Esmatjes3, J. Ferrer2, I. Revuelta1, D. Cucchiari1, J. Rovira4, M. Musquera5, C. Fondevila2, F. Diekmann1, P. Ventura-Aguiar1

    1Nephrology and Kidney Transplantation Department, Hospital Clinic de Barcelona, Barcelona, Spain, 2Hepatobiliopancreatic and Liver Transplant Department, Hospital Clinic de Barcelona, Barcelona, Spain, 3Endocrinology Department, Hospital Clinic de Barcelona, Barcelona, Spain, 4Laboratori Experimental de Nefrologia I Trasplantament (LENIT), CRB CELLEX, Fundació Clínic, IDIBAPS, Hospital Clinic de Barcelona, Barcelona, Spain, 5Urology Department, Hospital Clinic de Barcelona, Barcelona, Spain

    *Purpose: Hyperglycemia requiring insulin treatment is frequent in critically ill patients and potential pancreas donors. Information on the impact of donor insulin use on pancreas…
  • 2021 American Transplant Congress

    Human Leukocyte Antigen Mismatches Between Donor-Recipient or Donor-Donor are Not Associated with Adverse Pancreas Outcomes in Pancreas After Kidney Transplant Recipients

    S. Parajuli, D. Kaufman, B. Welch, H. Sollinger, D. Mandelbrot, J. Odorico

    University of Wisconsin, MADISON, WI

    *Purpose: A greater degree of HLA mismatch has been previously associated with inferior graft survival in kidney and pancreas transplantation. Pancreas after kidney (PAK) recipients…
  • 2021 American Transplant Congress

    Early Increases in Post-Transplant Pancreatic Enzymes are Not Associated with Inferior Patient or Graft Outcomes Among Pancreas Transplant Recipients

    S. Parajuli, G. E. Leverson, B. Welch, H. Sollinger, D. Kaufman, D. Mandelbrot, J. Odorico

    University of Wisconsin, Madison, WI

    *Purpose: An increase in the serum concentration of pancreatic enzymes (amylase and lipase) is commonly related to an acute inflammatory process in the pancreas graft…
  • 2021 American Transplant Congress

    Risk Factors for the Development of Posttransplant Lymphoproliferative Disorder (ptld) After Pancreas Transplantation- A Registry Analysis

    A. Gruessner, S. Saggi, J. Renz, R. Gruessner

    SUNY Downstate Medical Center, Brooklyn, NY

    *Purpose: A pancreas transplant provides patients with brittle diabetes the opportunity of good long-term metabolic control. However, it requires long-term immunosuppression with its associated risks…
  • 2021 American Transplant Congress

    Early Increases in Post-Transplant Pancreatic Enzymes Are Associated with Surgical Complications Among Pancreas Transplant Recipients

    S. Parajuli, G. Leverson, B. Welch, H. Sollinger, D. Kaufman, D. Mandelbrot, J. Odorico

    University of Wisconsin, Madison, WI

    *Purpose: An increase in the serum concentration of pancreatic enzymes (amylase and lipase) is commonly related to an acute inflammatory process in the pancreas graft…
  • 2021 American Transplant Congress

    Simultaneous Pancreas-kidney Transplantation (spk) and, Simultaneous Deceased Donor Pancreas and Living Donor Kidney Transplantation (splk) in Diabetic Patients with End Stage Renal Disease

    Y. Ko

    Department of Surgery, Asan Medical Center, Seoul, Korea, Republic of

    *Purpose: The purpose of this study is to compare clinical outcomes of simultaneous pancreas-kidney transplantation (SPK) and simultaneous deceased donor pancreas and living donor kidney…
  • 2021 American Transplant Congress

    Corticosteroid Reintroduction in Urban Simultaneous Kidney-pancreas Transplant Recipients Following an Early Corticosteroid Withdrawal Protocol

    D. Pierce, P. West-Thielke, M. Campara, I. Tang, M. Spaggiari, I. Tzvetanov, E. Benedetti, A. Lichvar

    University of Illinois at Chicago, Chicago, IL

    *Purpose: Approximately 30% of patients who undergo simultaneous kidney-pancreas (SKP) transplant are maintained on dual therapy with tacrolimus and mycophenolate. Long-term implications of steroid reintroduction…
  • 2021 American Transplant Congress

    Outcomes of Simultaneous Pancreas-Kidney Transplants from Donation After Circulatory Death Donors in the UK: A National Registry Analysis

    N. Karydis1, M. Ibrahim2, C. Counter2, J. Casey3, P. Friend4, C. Watson5, C. Callaghan1

    1Nephrology and Transplantation, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom, 2NHS Blood and Transplant, Bristol, United Kingdom, 3Transplant Unit, Royal Infirmary of Edinburgh, Edinburgh, United Kingdom, 4Nuffield Department of Surgical Sciences, University of Oxford, Oxford, United Kingdom, 5Department of Surgery, Addenbrooke's Hospital and Cambridge NIHR Biomedical Research Campus, Cambridge, United Kingdom

    *Purpose: The UK is a world leader in the use of pancreases from donation after circulatory death (DCD) donors. However, there is a perception that…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 28
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences